BioLineRx In-Licenses Two Additional Drug Candidates.

Business WireMarch 26, 2007

Linked as:

Extract


BioLineRx In-Licenses Two Additional Drug Candidates.

- Company Expands Therapeutic Pipeline to Fourteen by Signing Four In-Licensing Agreements in 2007 -

JERUSALEM, Israel -- BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, today announced that it has signed in-license agreements to develop and commerci...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company